Skip to main content
DEMO ENVIRONMENT | GROWTH CLIENT TIER | ALL DATA IS ILLUSTRATIVE — NO LIVE API CONNECTIONS
AIMWELLBIO FHIN · v2.1.0
CLIENT Trial Signal Shield Command Growth Enterprise Alumni Partner FHIN Observer Contributor Researcher Institutional Community →
Active Signals
312
+47 this week across 5 clusters
Synapse Runs
14
3 PROCEED · 7 DELAY · 4 KILL
FHIN Contributors
8,435
+128 contributors in last 30 days
Swarm Confidence
0.92
Avg across active validations
FHIN SWARM · 5 INDICATION CLUSTERS
Oncology Metabolic Neuroscience Immunology Cardiovascular

Synapse Intelligence

PROCEED
CV outcome trial design (sponsor B)
Adversarial validation · 9 contributors · 0.91 confidence
DELAY
Phase 2 expansion in solid-tumor cohort
Adversarial validation · 11 contributors · 0.68 confidence
KILL
Surrogate endpoint reliance in late-stage neuro
Adversarial validation · 14 contributors · 0.83 confidence
PROCEED
Biomarker registry submission (immunology)
Adversarial validation · 7 contributors · 0.88 confidence

Top Research Areas

Oncology32%
Metabolic24%
Neuroscience18%
Immunology15%
Cardiovascular11%

Your Growth Network

Indications tracked5 of 5
SYNAPSE runs (month)3 of 5
Contributors followed142
Cross-cluster signals (week)23 ↑

What would change if you saw the entire network graph as it shifts?

Enterprise unlocks every cluster, every cross-indication thread, every adversarial validation in flight. Move from watching five indications to operating on the whole graph.

Unlimited SYNAPSE sessions Full network graph access Portfolio-impact heatmap Dedicated account team API + custom integrations
Initiate Enterprise Setup →
100+ CONTRIBUTORS · 32 REGIONS · ONE INTELLIGENCE NETWORK